1. Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996; 103:2070-9;
2. Gawecki M, Groszewska E. Central serous chorioretinopathy during pregnancy complicated by systemic hypertension - a case report. Klin Oczna. 2016; 117:256-259
3. Giovansili I, Belange G, Affortit A. Cushing disease revealed by bilateral atypical central serous chorioretinopathy: case report. Endocr Pract. 2013; 19 : 129-33
4. Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol. 2008; 86:126-45
5. Chatziralli I, Kabanarou SA, Parikakis E, Chatzirallis A, Xirou T, Mitropoulos P. Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study. Curr Eye Res. 2017; 42:1069-1073
6. Islam QU, Hanif MK, Tareen S. Frequency of Systemic Risk Factors in Central Serous Chorioretinopathy. J Coll Physicians Surg Pak. 2016; 26:692-5
7. Liu B, Deng T, Zhang J. Risk factors for central serous chorioretinopathy: a systematic review and meta-analysis. Retina.2016; 36:9-19
8. Çiloğlu E, Unal F, Dogan NC. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels. Graefes Arch Clin Exp Ophthalmol. 2018; 256:1111-1116
9. Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients. Br J Ophthalmol. 2018; Jul 12. pii: bjophthalmol-2018-312431
10. Mrejen S, Spaide RF. Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol. 2013; 58:387-429.
11. Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina. 1996; 16:203-13.
12. Yannuzzi LA . Indocyanine green angiography: a perspective on use in the clinical setting. Am J Ophthalmol. 2011; 151:745-751.
13. Hirami Y, Tsujikawa A, Sasahara M, Gotoh N, Tamura H, Otani A, Mandai M, Yoshimura N. Alterations of retinal pigment epithelium in central serous chorioretinopathy. Clin Exp Ophthalmol. 2007; 35:225-30
14. Ahlers C, Geitzenauer W, Stock G, Golbaz I, Schmidt-Erfurth U, Prünte C. Alterations of intraretinal layers in acute central serous chorioretinopathy. Acta Ophthalmol. 2009; 87:511-6
15. Luttrull JK. Low-intensity/high-density subthreshold diode micropulse laser for central serous chorioretinopathy. Retina. 2016; 36:1658-6316
16. Scholz P, Ersoy L, Boon CJ, Fauser S. Subthreshold Micropulse Laser (577 nm) Treatment in Chronic Central Serous Chorioretinopathy. Ophthalmologica. 2015; 234:189-94
17. Yadav NK, Jayadev C, Mohan A, Vijayan P, Battu R, Dabir S et al. Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome. Eye. 2015; 29:258-64
18. Kim JY, Park HS, Kim SY. Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2015; 253:2129-35
19. Malik KJ, Sampat KM, Mansouri A, Steiner JN, Glaser BM. Low-intensity/high-density subthreshold microPulse diode laser for chronic central serous chorioretinopathy. Retina. 2015; 35:532-6
20. Roca JA, Wu L, Fromow-Guerra J, Rodríguez FJ, Berrocal MH, Rojas S, Lima LH, Gallego-Pinazo R, Chhablani J, Arevalo JF, Lozano-Rechy D, Serrano M. Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group. Br J Ophthalmol. 2018; Feb 8. pii: bjophthalmol-2017-311291.
21. Arsan A, Kanar HS, Sonmez A. Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up. Eye. 2018; 32:726-733
22. Abd Elhamid AH. Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy. Clin Ophthalmol. 2015; 9:2277-83.
23. Koss MJ, Beger I, Koch FH. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye. 2012;26:307-14
24. Scholz P, Altay L, Fauser S. A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders. Adv Ther. 2017 Jul;34(7):1528-1555
25. Mohabati D, van Dijk EH, van Rijssen TJ, de Jong EK, Breukink MB, Martinez-Ciriano JP, Dijkman G, Hoyng CB, Fauser S, Yzer S, Boon CJ. Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy. Clin Ophthalmol. 2018 Oct 24;12:2167-2176
26. Liu Y, Li L, Zhu EY, Yuan Y, Wang W, Xu G. A two-year study of diffused retinal pigment epitheliopathy treated with half-dose photodynamic therapy guided by simultaneous angiography and optical coherence tomography. Eye (Lond). 2018 Dec 7. doi: 10.1038/s41433-018-0284-z.
27. Sheptulin V, Purtskhvanidze K, Roider J. Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2027-2034
28. Ladas ID, Andreanos KD, Ladas DS, Moschos MM, Rotsos T, Kotsolis AI. Three-Year Results of Fluorescein Angiography-Guided Standard Photodynamic Therapy with Multiple Spots for Central Serous Chorioretinopathy. Ophthalmol Retina. 2018 Jul;2(7):703-711
29. Ruiz-Del-Tiempo MP, Calvo P, Ferreras A, Leciñena J, Pablo L, Ruiz-Moreno O. Anatomical Retinal Changes after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy. J Ophthalmol. 2018 Feb 6;2018:4081874. doi: 10.1155/2018/4081874
30. Kretz FT, Beger I, Koch F, Nowomiejska K, Auffarth GU, Koss MJ. Randomized Clinical Trial to Compare Micropulse Photocoagulation Versus Half-dose Verteporfin Photodynamic Therapy in the Treatment of Central Serous Chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina. 2015 Sep;46(8):837-43
31. Scholz P, Altay L, Fauser S. Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy. Eye (Lond). 2016 Oct;30(10):1371-1377
32. Özmert E, Demirel S, Yanık Ö, Batıoğlu F. Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy. J Ophthalmol. 2016;2016:3513794. doi: 10.1155/2016/3513794
33. van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF. Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial. Ophthalmology. 2018; May 15. pii: S0161-6420(17)33463-2
34. Wang SK, Sun P, Tandias RM, Seto BK, Arroyo JG. Mineralocorticoid Receptor Antagonists in Central Serous Chorioretinopathy: A Meta-Analysis of Randomized Controlled Trials. Ophthalmol Retina. 2019 Feb;3(2):154-160
35. Schwartz R, Habot-Wilner Z, Martinez MR, Nutman A, Goldenberg D, Cohen S, Shulman S, Guzner-Gur H, Loewenstein A, Goldstein M. Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study. Acta Ophthalmol. 2017 Nov;95(7):e610-e618
36. Rahimy E, Pitcher JD 3rd, Hsu J, Adam MK, Shahlaee A, Samara WA, Vander JF, Kaiser RS, Chiang A, Spirn MJ, Fineman MS. A randomized double-blind placebo-control pilot study of eplerenone for the treatment of central serous chorioretinopathy (Ecselsior). Retina. 2018 May;38(5):962-969
37. Cakir B, Fischer F, Ehlken C, Bühler A, Stahl A, Schlunck G, Böhringer D, Agostini H, Lange C. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2016 Nov;254(11):2151-2157
38. Ficker L, Vafidis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol. 1988 Nov;72(11):829-34
39. Chhablani J, Rani PK, Mathai A, Jalali S, Kozak I. Navigated focal laser photocoagulation for central serous chorioretinopathy. Clin Ophthalmol. 2014 Aug 18;8:1543-7. doi: 10.2147/OPTH.S67025
40. Breukink MB, Dingemans AJ, den Hollander AI, Keunen JE, MacLaren RE, Fauser S, Querques G, Hoyng CB, Downes SM, Boon CJ. Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Clin Ophthalmol. 2016; 11:39-46
41. Rochepeau C, Kodjikian L, Garcia MA, Coulon C, Burillon C, Denis P, Delaunay B, Mathis T. OCT-Angiography Quantitative Assessment of Choriocapillaris Blood Flow in Central Serous Chorioretinopathy. Am J Ophthalmol. 2018; Jul 24. pii: S0002-9394(18)30385-4. doi: 10.1016/j.ajo.2018.07.004. [Epub ahead of print]
42. Cakir B, Reich M, Lang SJ, Bühler A, Stahl A, Böhringer D, Agostini H, Lange C. Possibilities and Limitations of OCT-Angiography in Patients with Central Serous Chorioretinopathy]. Klin Monbl Augenheilkd. 2017; 234:1161-1168
43. Matet A, Daruich A, Hardy S, Behar-Cohen F. Patterns of choriocapillaris flow signal voids in central serous chorioretinopathy: An Optical Coherence Tomography Angiography Study. Retina. 2018; Jul 17. doi: 10.1097/IAE.0000000000002271. [Epub ahead of print]
44. Cardillo Piccolino F, Lupidi M, Cagini C, Fruttini D, Nicolò M, Eandi CM, Tito S. Choroidal Vascular Reactivity in Central Serous Chorioretinopathy. Invest Ophthalmol Vis Sci. 2018; 59:3897-3905.
45. Costanzo E, Cohen SY, Miere A, Querques G, Capuano V, Semoun O, El Ameen A, Oubraham H, Souied EH. Optical Coherence Tomography Angiography in Central Serous Chorioretinopathy. J Ophthalmol. 2015:134783
46. Toto L, D'Aloisio R, Mastropasqua R, Di Antonio L, Di Nicola M, Di Martino G, Evangelista F, Erroi E, Doronzo E, Mariotti C. Anatomical and Functional Changes of the Retina and the Choroid after Resolved Chronic CSCR. J Clin Med. 2019 Apr 7;8(4)
47. Fujita K, Kawamura A, Yuzawa M. Choriocapillaris Changes Imaged by OCT Angiography After Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina. 2017 Apr 1;48(4):302-310
48. Xu Y, Su Y, Li L, Qi H, Zheng H, Chen C. Effect of Photodynamic Therapy on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy. Ophthalmologica. 2017;237(3):167-172
49. Gawęcki M, Jaszczuk-Maciejewska A, Jurska-Jaśko A, Grzybowski A. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser. Graefes Arch Clin Exp Ophthalmol. 2017; 255:2299-2306
50. Gass JDM (1987) Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. 3rd ed. Mosby, St. Louis, pp 46-59
51. Khosla PK, Rana SS, Tewari HK, Azad RU, Talwar D. Evaluation of visual function following argon laser photocoagulation in central serous retinopathy. Ophthalmic Surg Lasers. 1997; 28:693-7
52. Arora S, Sridharan P, Arora T, Chhabra M, Ghosh B. Subthreshold diode micropulse laser versus observation in acute central serous chorioretinopathy. Clin Exp Optom. 2018; Jul 30. doi: 10.1111/cxo.12818. [Epub ahead of print]
53. Goldhagen BE, Goldhardt R. Diagnosed a Patient with Central Serous Chorioretinopathy? Now What?: Management of Central Serous Chorioretinopathy. Curr Ophthalmol Rep. 2017; 5:141-148
54. Salehi M, Wenick AS, Law HA, Evans JR, Gehlbach P. Interventions for central serous chorioretinopathy: a network meta-analysis. Cochrane Database Syst Rev. 2015; 12:CD011841
55. Wong KH, Lau KP, Chhablani J, Tao Y, Li Q, Wong IY. Central serous chorioretinopathy: what we have learnt so far. Acta Ophthalmol. 2016; 94:321-5